檢索結果

在您的搜尋 主題建議
Refine Results
  1. 1
    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy 由 Roberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, Matteo Santoni, Patrizia Trenta, Angelina De Benedetto, Silvia Mezi, Enrico Cortesi

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Recent advances in the treatment of metastatic renal cell carcinoma

    Recent advances in the treatment of metastatic renal cell carcinoma 由 Hideyuki Abe, Takao Kamai

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

    Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway 由 Ole‐Petter R. Hamnvik, Toni K. Choueiri, Alexander Turchin, Rana R. McKay, Lipika Goyal, Michael Davis, Marina D. Kaymakcalan, Jonathan S. Williams

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Health‐related quality‐of‐life results from PALETTE: A randomized, double‐blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

    Health‐related quality‐of‐life results from PALETTE: A randomized, double‐blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has pr... 由 Corneel Coens, Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla, Ian Judson, Roberta Sanfilippo, Stephanie Manson, Rachel Hodge, Sandrine Marréaud, Judith B. Prins, Iwona Ługowska, Saskia Litière, Andrew Bottomley

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma—a suitable treatment option: case report and review of anti-angiogenic treatment options

    Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma—a suitable treatment option: case report and review of anti-angiogenic treatment options 由 Valeriya Semenisty, Inna Naroditsky, Zohar Keidar, Gil Bar‐Sela

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases

    Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases 由 Sarathi Kalra, Bradley J. Atkinson, Marc Matrana, Surena F. Matin, Christopher G. Wood, José A. Karam, Pheroze Tamboli, Kanishka Sircar, Priya Rao, Paul G. Corn, Nizar M. Tannir, Eric Jonasch

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials

    Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials 由 Matteo Santoni, Alessandro Conti, Francesco Massari, Giorgio Arnaldi, Roberto Iacovelli, Mimma Rizzo, Ugo De Giorgi, Laura Trementino, Giuseppe Procopio, Giampaolo Tortora, Stefano Cascinu

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Potential Therapeutic Targets in Uterine Sarcomas

    Potential Therapeutic Targets in Uterine Sarcomas 由 Tine Cuppens, Sandra Tuyaerts, Frédéric Amant

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice

    Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice 由 Yukihiko Hiroshima, Ming Zhao, Yong Zhang, Nan Zhang, Ali Maawy, Takashi Murakami, Sumiyuki Mii, Fuminari Uehara, Mako Yamamoto, Shinji Miwa, Shuya Yano, Masashi Momiyama, Rintaro Mori, Ryusei Matsuyama, Takashi Chishima, Kuniya Tanaka, Yasushi Ichikawa, Michael Bouvet, Itaru Endo, Robert M. Hoffman

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

    New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions 由 Makoto Chuma, Katsumi Terashita, Naoya Sakamoto

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR‐TKIs and mTOR inhibitor

    Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR‐TKIs and mTOR inhibitor 由 Matteo Santoni, Rossana Berardi, Consuelo Amantini, Luciano Burattini, Daniele Santini, Giorgio Santoni, Stefano Cascinu

    出版 2013
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Incidence and risk of hypertension with a novel multi‐targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta‐analysis

    Incidence and risk of hypertension with a novel multi‐targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta‐analysis 由 Wei‐Xiang Qi, Aina He, Zan Shen, Yang Yao

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

    A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer 由 Massimo Cristofanilli, Stephen Johnston, Alexey Manikhas, Henry Gómez, Oleg Gladkov, Zhimin Shao, Sufia Safina, Kimberly Blackwell, Ricardo H. Álvarez, Stephen D. Rubin, Sulabha Ranganathan, Suman Redhu, Maureen Trudeau

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options

    Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options 由 Laura Desch, Rainer Kunstfeld

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

    Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors 由 Jacqueline S. L. Kloth, Alessia Pagani, Michiel C. Verboom, Alberto Malovini, Carlo Napolitano, Wim H.J. Kruit, Stefan Sleijfer, Neeltje Steeghs, Alberto Zambelli, Ron H.J. Mathijssen

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells

    Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells 由 Brunilde Gril, Diane Palmieri, Yongzhen Qian, Talha Anwar, David J. Liewehr, Seth M. Steinberg, Zoraida Andreu, Daniel Masana, Paloma Fernández, Patricia S. Steeg, Fernando Vidal‐Vanaclocha

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs

    A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs 由 Éric Guérin, Shan Man, Ping Xu, Robert S. Kerbel

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

    The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma 由 Klaus Podar, Giovanni Tonon, Martin Sattler, Yu‐Tzu Tai, Steven Le Gouill, Hiroshi Yasui, Kenji Ishitsuka, Shaji Kumar, Rakesh Kumar, Lini Pandite, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

    Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortiu... 由 Julia Glade Bender, Alice Lee, Joel M. Reid, Sylvain Baruchel, Timothy P. L. Roberts, Stephan D. Voss, Bing Wu, Charlotte H. Ahern, Ashish M. Ingle, Pamela Jo Harris, Brenda J. Weigel, Susan M. Blaney

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)

    PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA) 由 Wagner Eduardo Matheus, Marcela Durán, O Clark, Atul Kumar, Ubirajara Ferreira, T.E.A. Botrel

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: